The intersection of two major infectious disease outbreaks reveals how pandemic responses can influence mortality patterns in unexpected ways. Analysis of mpox surveillance data across 20 African countries demonstrates a dramatic reduction in case fatality rates as COVID-19 pandemic measures were lifted, suggesting that healthcare system strain during the pandemic may have worsened outcomes for other diseases.
Researchers tracked 9,446 confirmed mpox cases from January 2022 through September 2024, finding an overall case fatality rate of 0.58%. However, this masked a significant temporal shift: during the COVID-19 pandemic phase (through May 2023), mpox fatality reached 1.16%, compared to just 0.46% in the post-pandemic period. The Democratic Republic of Congo bore the heaviest burden, accounting for over three-quarters of all cases. Different viral clades showed varying lethality patterns, with clade Ia and Ib combined carrying 4.46 times higher mortality risk than clade Ia alone.
This finding challenges assumptions about how overlapping health crises interact. Rather than creating synergistic mortality effects, the data suggests healthcare systems may have adapted their infectious disease protocols during the transition period, leading to improved mpox outcomes. The research highlights a critical blind spot in pandemic preparedness: how primary outbreak responses inadvertently affect care for concurrent diseases. For health-conscious adults, this underscores the importance of maintaining routine healthcare engagement even during crisis periods, as system-level factors can significantly influence individual disease outcomes beyond the pathogen's inherent severity.